Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Discover various ways to diversify your income sources, increasing your earning potential and financial resilience.
20,225 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
The NRC granted TerraPower a construction permit for a sodium-cooled reactor in Wyoming, marking a watershed for adva...
VFVA has posted solid gains by targeting cheap U.S. equities, but a hidden volatility risk lies in its deep value app...
Funds that rode big EM winners are rotating out of maxed TSMC and Samsung Hynix and chasing new catalysts. The shift ...
Amazon's potential shift to selling its Trainium AI chips could shake up the AI hardware landscape. This article brea...
Fidelity Investments’ leadership, led by Abby Johnson, has quietly built a decades-long crypto program that critics n...
Korea’s tech-heavy KOSPI has surged roughly 75% since January, outpacing even the hottest Nasdaq plays. The year’s be...
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
Executives from SpaceX and Charter are in early talks about a consumer mobile service that could route SpaceX phone t...
Kazakhstan's central bank is considering a $350 million crypto-related portfolio funded in part by gold reserves. Off...
A dramatic rise in gold shipments from the United States propelled exports to new highs in early 2026, signaling a sh...
Tirana faces clashes as a Kushner-linked coastal project draws environmental ire and public skepticism. Officials pro...